Therapeutic benefits of gonadotropins in male hypogonadotropic hypogonadism: a focus on spermatogenesis and fertility.

Reprod Fertil · 2026 · PMC13280620 · PMID 42189927

Europe PMC DOI

hedged sentences

0.0590

closest p · 1.2× alpha

0.0730

boldest claim

The sentences

borderline significanceP = 0.059so close (0.05 < p ≤ 0.1)

Univariate linear regression ( Table 5 ) identified baseline testicular volume as the only significant predictor of total motile sperm count ( P = 0.034), while the duration of gonadotropin and FSH therapy showed borderline significance ( P = 0.059 and P = 0.075, respectively).

also in 7,017 other papers

showed a trendP = 0.073so close (0.05 < p ≤ 0.1)

The presence of cryptorchidism showed a trend toward a longer time to achieve spermatogenesis ( P = 0.073).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.